Sökning: onr:"swepub:oai:lup.lub.lu.se:79b433e1-c0f9-4e10-b092-3e9503d4b425" >
Complementarity-det...
Complementarity-determining region (CDR) implantation : A theme of recombination
-
- Söderlind, Eskil (författare)
- BioInvent Therapeutic AB
-
- Ohlin, Mats (författare)
- Lund University,Lunds universitet,Institutionen för immunteknologi,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Immunotechnology,Departments at LTH,Faculty of Engineering, LTH
-
- Carlsson, Roland (författare)
- BioInvent Therapeutic AB
-
(creator_code:org_t)
- 1999
- 1999
- Engelska 7 s.
-
Ingår i: Immunotechnology. - 1380-2933. ; 4:3-4, s. 279-285
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- A novel technology in the area of antibody engineering has been developed which allows for the creation of new types of antibody molecules. It is called complementarity-determining region (CDR) implantation and permits the random combination of CDR sequences formed in vivo into a single master framework. Thus, totally new gene combinations can be produced and used in selection processes. The result is a genetic variability which is extremely large, even exceeding the natural variability found in the immune system. In this commentary, CDR implantation is presented and the technology is discussed.
Nyckelord
- Antibody engineering
- CDR implantation
- Complementarity-determining region
- Genetic variation
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas